Company's CEO says success in the human trial of administering an inhaled version of remdesivir could represent 'important progress'
Actualités similaires
Articles similaires à Gilead to Begin Human Trials of Inhaled Version of Potential Anti-COVID Drug
Up to 90 healthy volunteers will be deliberately infected with virus with goal of developing more effective vaccines and treatments
Actualités similaires
Company's CEO says success in the human trial of administering an inhaled version of remdesivir could represent 'important progress'
Actualités similaires